Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes

被引:1
|
作者
Losada-Diaz, Federico [1 ]
Lizarazo-Bocanegra, Santiago [1 ]
Perdomo-Lugo, Juan J. [1 ]
Gutierrez-Romero, Sebastian A. [1 ]
Correa-Osio, Isabella [1 ]
Mendivil, Carlos O. [1 ,2 ]
机构
[1] Univ Andes, Sch Med, Bogota, Colombia
[2] Fdn Santa Fe Bogota, Dept Internal Med, Sect Endocrinol, Bogota, Colombia
关键词
Obesity; Diabetes; Weight loss; GLP-1; agonists; Bariatric surgery; OBESE-PATIENTS; BODY-WEIGHT; BARIATRIC SURGERY; RECEPTOR AGONISTS; TYPE-2; OVERWEIGHT; ADULTS; LIRAGLUTIDE; SEMAGLUTIDE; LIFE;
D O I
10.1007/s13300-024-01646-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is both a major risk factor for diabetes and a serious comorbidity of the condition. The twin epidemics of obesity and diabetes have spread globally over the past few decades. Treatment of obesity in patients with diabetes provides a host of clinical benefits that encompass virtually all body systems. Despite this, multiple lines of evidence suggest that the efficacy of most therapies for weight loss is significantly reduced among patients with diabetes. With this background, we summarize the evidence of a differential effect of lifestyle, pharmacological, and surgical treatments for obesity in patients with existing diabetes, and explore the potential mechanisms involved in this phenomenon. This information is then used to formulate strategies to improve weight loss outcomes for patients with diabetes.
引用
收藏
页码:2279 / 2291
页数:13
相关论文
共 50 条
  • [31] Weight-Loss Interventions in Patients with Overweight/Obesity and CKD
    Chang, Ryan
    Frost, Livia Ann
    Navaneethan, Sankar D.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [32] Weight loss interventions for patients with prostate cancer: a scoping review
    Yeary, Karen Hye-cheon Kim
    Yu, Han
    Varady, Krista
    Tang, Li
    NUTRITION REVIEWS, 2024, 83 (03) : e1197 - e1208
  • [33] Weight Loss Interventions in Adults
    Tsai, Adam G.
    Apovian, Caroline
    Kaplan, Lee
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (09): : 900 - 900
  • [34] LOW UTILIZATION OF EFFECTIVE WEIGHT LOSS INTERVENTIONS IN PATIENTS WITH NAFLD
    Gibson, Elena
    Kucharski, Kim
    Wu, Chaorong
    Tuan Pham
    GASTROENTEROLOGY, 2022, 162 (07) : S1276 - S1277
  • [35] Metabolite signature of diabetes remission in individuals with obesity undergoing weight loss interventions
    Thaker, Vidhu V.
    Kwee, Lydia Coulter
    Chen, Haiying
    Bahnson, Judy
    Ilkayeva, Olga
    Muehlbauer, Michael J.
    Wolfe, Bruce
    Purnell, Jonathan Q.
    Pi-Sunyer, Xavier
    Newgard, Christopher B.
    Shah, Svati H.
    Laferrere, Blandine
    OBESITY, 2024, 32 (02) : 304 - 314
  • [36] DIET MONITORING FOR GESTATIONAL DIABETES, WEIGHT-LOSS INTERVENTIONS AND PERSONALIZED NUTRITION
    Hernando, M. E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A15 - A16
  • [37] Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature
    Gostoli, Sara
    Raimondi, Giulia
    Popa, Alexandra Paula
    Giovannini, Micaela
    Benasi, Giada
    Rafanelli, Chiara
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 224 - 241
  • [38] Off Label Use of Oral Semaglutide Has Weight Loss Benefit in Obese Patients without Diabetes
    West, William
    Romo, Karina
    Zaidi, Raza
    Zia, Abdul
    Noor, Abdullah
    Uwaifo, Gabriel
    OBESITY, 2021, 29 : 133 - 133
  • [39] Differential adaptation of human gut microbiota to weight loss and diabetes remission achieved by gastric bypass versus sleeve gastrectomy
    Murphy, R.
    Tsai, P.
    Plank, L.
    Booth, M.
    DIABETOLOGIA, 2015, 58 : S111 - S111
  • [40] Orlistat enhances weight loss in obese patients with diabetes
    Hollander, P
    AMERICAN FAMILY PHYSICIAN, 1997, 56 (02) : 566 - 566